Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Buy dildos, sex toys and adult toys.
Popular Articles

Management Insights Study Warns That State Privacy Rules Reduce Electronic Medical Sharing
States that have passed privacy laws restricting the ability of hospitals to disclose patient information have seen the sharing of electronic medical records suffer by more than 24%, according to the Management Insights feature in the current issue of Management Science, the flagship journal of the Institute for Operations Research and the Management Sciences (INFORMS®).
buy viagra
Programming Tools Facilitate Use Of Video Game Processors For Defense Needs
Video gaming computers and video game consoles available today typically contain a graphics processing unit (GPU), which is very efficient at manipulating and displaying computer graphics. However, the unit"s highly parallel structure also makes it more efficient than a general-purpose central processing unit for a range of complex calculations important to defense applications.
plan for health
News of the day
Acupuncture Aid For Diabetics, UK
More than 2.2 million people in Britain suffer from type 2 diabetes*, a chronic progressive disease which usually affects the over 40s. The number of people diagnosed with the disease has increased dramatically in recent years and this has been linked to the increase in sedentary lifestyles and obesity.
Sexual Health

Cellceutix Files Patent Application For Its Cancer Compound

Cellceutix Corporation (OTCBB: CTIX), announced it has filed a U.S. patent application covering pharmaceutical formulations of a compound referred to as Kevetrin™ and many novel compounds having similar structures to Kevetrin. These structures cover a large number of compounds that Cellceutix can look at as possible drug development candidates. The application covers the use of Kevetrin™ and the other compounds in various areas, including cancers. Cellceutix plans to file in other countries within a year of the U.S. filing. George Evans, CEO stated: "This is a very exciting time for Cellceutix. The compounds covered by this patent application are structurally very different from anti-cancer agents currently on the market. Quite frankly, it took us longer than we expected to file this patent application due to the additional compounds that presented themselves as Kevetrin™ related structures. The result is a patent with new and expanded claims that will provide a strong intellectual property base for Kevetrin and a large portfolio of possible compounds for future development. In the meantime, we"ve been doing some very interesting experiments with Kevetrin and with our psoriasis candidate, KM-133. We anticipate announcing study results over the coming weeks." Cellceutix


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009